Impact of sacubitril –valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design
ConclusionsIn the context of the SERVE‐HF study, physicians are waiting for new trials and alternative therapies. We sought to assess in the ENTRESTO‐SAS trial whether sacubitril–valsartan could improve the outcome of SDB in CHF patients.
Source: ESC Heart Failure - Category: Cardiology Authors: Dany Jaffuel, Nicolas Molinari, Philippe Berdague, Atul Pathak, Michel Galinier, Marion Dupuis, Jean ‐Etienne Ricci, Jean‐Pierre Mallet, Arnaud Bourdin, François Roubille Tags: Study Design Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Complementary Medicine | Diovan | Heart | Heart Failure | Laboratory Medicine | Sleep Disorders | Sleep Medicine | Study